Overall survival

Median five year survival in adult AML patients (average age of 68 years) is approximately 25%.

However, overall survival rate is dependent on the patient’s age, with a five year survival rate being:

  • 40-50% for patients with previously untreated AML less than 50 years old
  • 10% for patients older than 60 years old

Overall survival rate is around 10% for patients with relapsed or refractory AML